Anne Spinewine

Clinical pharmacist, passionnate about contributing to better use of medications in clinical practice, and specifically in older adults.

[BE-SAFE @BESAFE_HORIZON]

🌟 Meet the first 2 inspiring individuals who successfully reduced or quit #sleepingpills and the contribution of #health professionals in their journey! Discover these real-life based stories. #BenzoAwarenessDay  (https://t.co/9GsuyXBwiO)

[BE-SAFE @BESAFE_HORIZON]

We are excited to introduce our first publication today: the Risks of Taking Sleeping Pills infographic, part of the BESAFE HORIZON EU project! Join us in raising awareness about the #benzodiazepines risks and discover the impact of healthy habits in our sleep #BenzoAwarenessDay

[Anne Spinewine @ASpinewine]

@OptimisingRxUse @deprescribing @DeprescribeAU @DeprescribeUS @CentMedUseSafet @MIPS_Australia @DeprescribeNet @NDeprescribing Super interesting paper, using a strong design to evaluate a policy initiative. Results do not show significant differences between groups BUT they provide valuable insights on how to advance deprescribing efforts!

[Anne Spinewine @ASpinewine]

Looking forward to meeting great people at #ICOD2 #deprescription. Let's register now!

[ICOD 2 @ICOD2024]

Deprescribers, register for the incoming ICOD2! 🇫🇷 💊

[deprescribing.org @deprescribing]

Scoping review shows #deprescribing recommendations are increasingly being incorporated into guidelines! 📈

However, detailed guidance on "how" to #deprescribe is still lacking: https://t.co/ChVLHbG0TH

More resources on "how" to #deprescribe here:
https://t.co/sx1AFeDwZd

[Anne Spinewine @ASpinewine]

Deprescribing networks worldwide are so inspiring to me and many others. Thanks @DrEmilyMcD for leading this report. Looking forward to future moments to network including #icod2!

[CADeN @DeprescribeNet]

Connecting with #deprescribing networks means more thought sharing, stronger initiatives & a greater impact.

We're so proud of our partnerships with @DeprescribeUS @DeprescribeAU @NDeprescribing!

Read the full article to know more about each network:
https://t.co/hG3YkmumZy

[Anne Spinewine @ASpinewine]

@deprescribing @CatherinePetein

[Anne Spinewine @ASpinewine]

Great opportunity to work on #deprescribing with @FrankMoriarty

[Frank Moriarty @FrankMoriarty]

Interested in pharmacoepi, deprescribing and big data?

We're hiring 4 researchers for a research programme @RCSIPharmBioMol funded by @wellcometrust to develop methods and generate evidence on the effects of deprescribing.

Links in the next tweet, D/L 22nd Apr, RTs appreciated!

[Anne Spinewine @ASpinewine]

I was so pleased to share at #SFPC2024 how #implementation science could move #clinicalpharmacy forward. Great conference and discussions!

[Rémy Collomp @CollompR]

#REX par une experte #implémentation @ASpinewine @UNamur @SFPCOfficiel #SFPC2024

[Anne Spinewine @ASpinewine]

2 weeks left to finalise abstracts on our latest #deprescribing research for #ICOD2024. We're almost ready. And you?

[ICOD 2 @ICOD2024]

⏱️Tik Tok⏱️16 days before the call for abstracts closes! Would you like to share your research or clinical experience? Do you have ideas for a workshop? Submit them before February 29! #ICOD2024

[Françoise VanBambeke @VanBambekeUCL]

🩺 How to omptimize the use of linezolid in clinical practice ? Read our last paper @ASpinewine :
Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers https://t.co/0m6N78IeZI

[Anne Spinewine @ASpinewine]

@PharmCareUCC @Pharmacy_UCC @perrine_evrard

[Anne Spinewine @ASpinewine]

ICOD2 is on its way! It's time to prepare our abstracts on #deprescribing to share them with this faulous international audience- Original research, clinical pearls and workshops.

[ICOD 2 @ICOD2024]

📣 Attention Deprescribers! 📣
The call for abstracts for the ICOD2 is open! We are welcoming original research, clinical pearls and workshop proposals for this issue.
👉🏻 Please connect on https://t.co/LyZwvfsTh4 for more information, and submit before February 29th, 2024! 🥳

[ICOD 2 @ICOD2024]

📣 Attention Deprescribers! 📣
The call for abstracts for the ICOD2 is open! We are welcoming original research, clinical pearls and workshop proposals for this issue.
👉🏻 Please connect on https://t.co/LyZwvfsTh4 for more information, and submit before February 29th, 2024! 🥳

[Emily Reeve @Reeve_Research]

Come and work with me! Research Fellow in Deprescribing
@DeprescribeAU @CentMedUseSafet @MonashPharm
https://t.co/DrsCSzP0nh

[Frank Moriarty @FrankMoriarty]

Closing date tomorrow for three post-doc position on the #MIDAS trial, evaluating social prescribing and pharmacist review in general practice.

@RCSIPharmBioMol @Pharmacy_UCC @TCDPharmacy @IrishPharmacy @PharmacistsIER

[Nicola McCleary @Nicola_McCleary]

Understanding how quality improvement interventions work is difficult without full intervention description
Pleased to share our work applying behavioural lens to surface active ingredients & causal assumptions of existing large-scale interventions (1/3) https://t.co/mWpj8NAiu0

[CMAJ_Open @CMAJ_Open]

Patient and public involvement in pragmatic trials:
The authors searched for pragmatic trials in MEDLINE and invited corresponding authors to participate in an online survey ➡️ https://t.co/IWD4rnsBmy

[Anne Spinewine @ASpinewine]

📢Today in @TheLancet: Beyond recos on the use of #benzodiazepines, recos on when and how to #deprescribe are needed. Beyond research on new drugs, we need research on approaches to deimplement practices that are widely used but jeopardize patients’ safety https://t.co/hdaZYjyYhE

[BE-SAFE @BESAFE_HORIZON]

📢 Our correspondence in @TheLancet emphasizes deprescribing for safer practices of #insomnia treatment in #olderadults. Check out the key points here🌐 https://t.co/ZFGlfLw0Od @BESAFE_HORIZON #Research #Patientsafety

[Justin Presseau @JPresseau]

We’re hiring x2! Research Coordinator (https://t.co/mrWe0G6sA2) to coordinate equity-focused BeSci & ImpSci qual studies & sys reviews in chronic disease, + Research Assistant (https://t.co/U3ora2oAS9) to support sys reviews & ethics apps in range of BeSci & ImplSci studies.